415 related articles for article (PubMed ID: 33924575)
1. Pathophysiological In Vitro Profile of Neuronal Differentiated Cells Derived from Niemann-Pick Disease Type C2 Patient-Specific iPSCs Carrying the
Liedtke M; Völkner C; Jürs AV; Peter F; Rabenstein M; Hermann A; Frech MJ
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924575
[TBL] [Abstract][Full Text] [Related]
2. Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Niemann-Pick Type C1.
Völkner C; Liedtke M; Hermann A; Frech MJ
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445799
[TBL] [Abstract][Full Text] [Related]
3. Generation of the Niemann-Pick type C2 patient-derived iPSC line AKOSi001-A.
Völkner C; Peter F; Liedtke M; Krohn S; Lindner I; Murua Escobar H; Cimmaruta C; Lukas J; Hermann A; Frech MJ
Stem Cell Res; 2019 Dec; 41():101606. PubMed ID: 31669975
[TBL] [Abstract][Full Text] [Related]
4. Diversity of glycosphingolipid GM2 and cholesterol accumulation in NPC1 patient-specific iPSC-derived neurons.
Trilck M; Peter F; Zheng C; Frank M; Dobrenis K; Mascher H; Rolfs A; Frech MJ
Brain Res; 2017 Feb; 1657():52-61. PubMed ID: 27923633
[TBL] [Abstract][Full Text] [Related]
5. Patient-Specific iPSC-Derived Neural Differentiated and Hepatocyte-like Cells, Carrying the Compound Heterozygous Mutation p.V1023Sfs*15/p.G992R, Present the "Variant" Biochemical Phenotype of Niemann-Pick Type C1 Disease.
Völkner C; Liedtke M; Untucht R; Hermann A; Frech MJ
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830064
[TBL] [Abstract][Full Text] [Related]
6. Molecular dynamics study with mutation shows that N-terminal domain structural re-orientation in Niemann-Pick type C1 is required for proper alignment of cholesterol transport.
Yoon HJ; Jeong H; Lee HH; Jang S
J Neurochem; 2021 Mar; 156(6):967-978. PubMed ID: 32880929
[TBL] [Abstract][Full Text] [Related]
7. Niemann-Pick C1 functions independently of Niemann-Pick C2 in the initial stage of retrograde transport of membrane-impermeable lysosomal cargo.
Goldman SD; Krise JP
J Biol Chem; 2010 Feb; 285(7):4983-94. PubMed ID: 20007703
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary abnormalities in animal models due to Niemann-Pick type C1 (NPC1) or C2 (NPC2) disease.
Roszell BR; Tao JQ; Yu KJ; Gao L; Huang S; Ning Y; Feinstein SI; Vite CH; Bates SR
PLoS One; 2013; 8(7):e67084. PubMed ID: 23843985
[TBL] [Abstract][Full Text] [Related]
9. Niemann-Pick type C1 patient-specific induced pluripotent stem cells display disease specific hallmarks.
Trilck M; Hübner R; Seibler P; Klein C; Rolfs A; Frech MJ
Orphanet J Rare Dis; 2013 Sep; 8():144. PubMed ID: 24044630
[TBL] [Abstract][Full Text] [Related]
10. Assessment of FDA-Approved Drugs as a Therapeutic Approach for Niemann-Pick Disease Type C1 Using Patient-Specific iPSC-Based Model Systems.
Völkner C; Pantoom S; Liedtke M; Lukas J; Hermann A; Frech MJ
Cells; 2022 Jan; 11(3):. PubMed ID: 35159129
[TBL] [Abstract][Full Text] [Related]
11. Oxidative Stress and Alterations in the Antioxidative Defense System in Neuronal Cells Derived from NPC1 Patient-Specific Induced Pluripotent Stem Cells.
Jürs AV; Völkner C; Liedtke M; Huth K; Lukas J; Hermann A; Frech MJ
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081384
[TBL] [Abstract][Full Text] [Related]
12. Niemann-Pick Disease Type C: Induced Pluripotent Stem Cell-Derived Neuronal Cells for Modeling Neural Disease and Evaluating Drug Efficacy.
Yu D; Swaroop M; Wang M; Baxa U; Yang R; Yan Y; Coksaygan T; DeTolla L; Marugan JJ; Austin CP; McKew JC; Gong DW; Zheng W
J Biomol Screen; 2014 Sep; 19(8):1164-73. PubMed ID: 24907126
[TBL] [Abstract][Full Text] [Related]
13. Targeting defective sphingosine kinase 1 in Niemann-Pick type C disease with an activator mitigates cholesterol accumulation.
Newton J; Palladino END; Weigel C; Maceyka M; Gräler MH; Senkal CE; Enriz RD; Marvanova P; Jampilek J; Lima S; Milstien S; Spiegel S
J Biol Chem; 2020 Jul; 295(27):9121-9133. PubMed ID: 32385114
[TBL] [Abstract][Full Text] [Related]
14. Activation of PKC triggers rescue of NPC1 patient specific iPSC derived glial cells from gliosis.
Peter F; Rost S; Rolfs A; Frech MJ
Orphanet J Rare Dis; 2017 Aug; 12(1):145. PubMed ID: 28841900
[TBL] [Abstract][Full Text] [Related]
15. ABCA1-dependent mobilization of lysosomal cholesterol requires functional Niemann-Pick C2 but not Niemann-Pick C1 protein.
Boadu E; Nelson RC; Francis GA
Biochim Biophys Acta; 2012 Mar; 1821(3):396-404. PubMed ID: 22179027
[TBL] [Abstract][Full Text] [Related]
16. A human iPSC-derived inducible neuronal model of Niemann-Pick disease, type C1.
Prabhu AV; Kang I; De Pace R; Wassif CA; Fujiwara H; Kell P; Jiang X; Ory DS; Bonifacino JS; Ward ME; Porter FD
BMC Biol; 2021 Oct; 19(1):218. PubMed ID: 34592985
[TBL] [Abstract][Full Text] [Related]
17. The Npc2
Rasmussen CLM; Thomsen LB; Heegaard CW; Moos T; Burkhart A
Mol Cell Neurosci; 2023 Sep; 126():103880. PubMed ID: 37454976
[TBL] [Abstract][Full Text] [Related]
18. Clinical and Molecular Features of Early Infantile Niemann Pick Type C Disease.
Seker Yilmaz B; Baruteau J; Rahim AA; Gissen P
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32709131
[TBL] [Abstract][Full Text] [Related]
19. Finding pathogenic commonalities between Niemann-Pick type C and other lysosomal storage disorders: Opportunities for shared therapeutic interventions.
Yañez MJ; Marín T; Balboa E; Klein AD; Alvarez AR; Zanlungo S
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165875. PubMed ID: 32522631
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of primidone in Niemann-Pick disease type C (NPC)-model cells and mice: Reduction of unesterified cholesterol levels in cells and extension of lifespan in mice.
Ashikawa H; Mogi H; Honda T; Nakamura H; Murayama T
Eur J Pharmacol; 2021 Apr; 896():173907. PubMed ID: 33503462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]